Metabolomic changes associated with frontotemporal lobar degeneration syndromes.
Alexander G MurleyP Simon JonesIan Coyle GilchristLucy BownsJulie WigginsKamen A TsvetanovJames B RowePublished in: Journal of neurology (2020)
The metabolic changes in FTLD are promising diagnostic and prognostic biomarkers. Further work is required to replicate these findings, examine longitudinal change, and test their utility in differentiating between FTLD syndromes that are pathologically distinct but phenotypically similar.